Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients With Intractable Cancer-Related Pain
Journal of Pain and Symptom Management, 11/09/09
Fallon MT et al. – This study shows that tetrahydrocannabinol:cannabidiol (THC:CBD) extract extract is efficacious for relief of pain in patients with advanced cancer pain not fully relieved by strong opioids.
Related Articles
Core Aspects of Satisfaction with Pain Management: Cancer Patients' Perspectives
Journal of Pain and Symptom Management, 11/02/09
Relevance Score: 68%
Outpatient Continuous Interscalene Brachial Plexus Block in Cancer-Related Pain
Journal of Pain and Symptom Management, 11/03/09
Relevance Score: 67%
Global perspectives on cancer pain
Pain Research and Management, 10/27/09
Relevance Score: 67%
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS hydromorphone in patients with chronic cancer pain
BMC Palliative Care, 10/16/09
Relevance Score: 67%
A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial
Current Medical Research and Opinion, 10/08/09
Relevance Score: 67%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09
Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection
The Journal of Urology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


